A Clinical Trial to Evaluate the Efficacy of an Oral Supplement in Supporting Vision and Eye Health

NCT ID: NCT06515457

Last Updated: 2024-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-22

Study Completion Date

2024-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the efficacy of BioNatureHealth's Eye Empower supplement in supporting vision and eye health. It is a virtual, single-group trial lasting 3 weeks. Participants will take three capsules of the supplement daily and complete questionnaires at Baseline, Week 1, Week 2, and Week 3 to assess visual clarity, dryness, symptoms of inflammation, and sensitivity to blue light.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammation Symptoms Eye Dryness Eye Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Eye Empower Supplement Arm

Participants in this arm will take three capsules of BioNatureHealth's Eye Empower supplement daily for three weeks.

Group Type EXPERIMENTAL

Eye Empower

Intervention Type DIETARY_SUPPLEMENT

Participants will take three capsules of the Eye Empower supplement daily for three weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Eye Empower

Participants will take three capsules of the Eye Empower supplement daily for three weeks.

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

BioNatureHealth Eye Empower

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female at birth, aged 40 or over
* Self-reported concerns about at least two of the following symptoms: dry eyes, red/itchy/irritated eyes, sensitivity to blue light, blurred vision (far or near)
* Generally healthy without uncontrolled chronic diseases
* Willing to avoid using new eye health prescriptions, over-the-counter medications, supplements, and herbal remedies for the study duration
* Consistent use of current eye health supplements or herbal remedies for at least 3 months prior to the study
* Willing to maintain current diet, sleep schedule, and activity level during the study

Exclusion Criteria

* Pre-existing chronic conditions preventing protocol adherence, including oncological and psychiatric disorders
* Diagnosed diabetes (Type I or II)
* Planning to undergo any eye-related procedures during the study
* Recent surgeries or invasive treatments within the last six months
* History of major illness within the last three months
* Recent use of a supplement with active ingredients in the test product
* Severe allergic reactions requiring an EpiPen, including shellfish allergy
* Pregnant, breastfeeding, or planning to conceive
* Use of medications or herbal supplements that impact the blood
* Non-consumption of animal products for religious or personal reasons
* Unwillingness to follow the study protocol
* Anyone with a history of drug or alcohol abuse
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Citruslabs

INDUSTRY

Sponsor Role collaborator

Bio Nature Health

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Citruslabs

Santa Monica, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20425

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dry Eye Assessment and Management: Feasibility Study
NCT01102257 COMPLETED PHASE2/PHASE3
Oral Nutrition Impact on Tear Film
NCT01561040 UNKNOWN PHASE4